Evaluating prognostic indicators for in-hospital mortality in Fournier's gangrene: a 7-year study in a tertiary hospital

Submitted: February 14, 2024
Accepted: February 19, 2024
Published: May 30, 2024
Abstract Views: 274
PDF: 22
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Background: Fournier's Gangrene Scoring Index (FGSI), Simplified FGSI (SFGSI), Uludag FGSI (UFGSI), Laboratory Risk Indicator for Necrotizing (LRINEC), Neutrophil-Lymphocyte ratio (NLR), and Platelet-lymphocyte ratio (PLR) have been devised to assess the risk of mortality in Fournier's Gangrene (FG) patients. However, the effectiveness of these indicators in predicting mortality at the time of admission remains uncertain. The aim of this study is to assess the prognostic efficacy of FG’s various indicators on in-hospital mortality.
Methods: This study analyzed 123 patients from Dr. Soetomo General Hospital’s emergency department in Indonesia from 2014 to 2020. Data included demographics, wound cultures, and parameters like FGSI, UFGSI, SFGSI, NLR, PLR, and LRINEC. In-hospital mortality status was also recorded. The data was subjected to comparative, sensitivity, specificity and regression analyses.
Results: In our study of 123 patients, the median age was 52, with a mortality rate of 17.9%. The majority of patients were male (91.1%) and the most common location was scrotal (54.5%). Non-survivors had a shorter median stay (6.5 days) compared to survivors (14 days). Diabetes was the most prevalent comorbidity (61.8%). The highest sensitivity and specificity were found in FGSI and UFGSI indicators. Multivariate logistic regression identified LoS and FGSI as independent predictors of mortality.
Conclusions: FGSI and UFGSI, upon admission, demonstrated the highest sensitivity and specificity, with hospital stay duration and FGSI as key mortality determinants.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Sorensen MD, Krieger, JN, Rivara FP, et al. Fournier's Gangrene: Management and Mortality Predictors in a Population Based Study. J Urol 2009; 182:2742-2747.
Laor E, Palmer LS, Tolia BM, et al. Outcome Prediction in Patients with Fournier's Gangrene. J Urol 1995; 89-92.
Yilmazlar T, Ozturk E, Ozguc H, et al. Fournier's gangrene: an analysis of 80 patients and a novel scoring system. Tech Coloproctol 2010; 14:217-223.
Lin TY, Ou CH, Tzai TS, et al. Validation and simplification of Fournier's gangrene severity index. Int J Urol 2014; 21:696-701.
Bozkurt O, Sen V, Demir O, Esen A. Evaluation of the utility of different scoring systems (FGSI, LRINEC and NLR) in the management of Fournier’s gangrene. Int Urol and Neph 2015; 47:243-248.
Wirjopranoto S. Comparison between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of mortality on Fournier's gangrene cases. Indian J Urol 2023; 39:121-125.
Ureyen O, Acar A, Gokcelli U, et al. Usefulness of FGSI and UFGSI scoring systems for predicting mortality in patients with Fournier's gangrene: A multicenter study. Ulus Travma Acil Cerrahi Derg 2017; 23:389-394.
Tutino R, Colli F, Rizzo G, et al. Which Role for Hyperbaric Oxygen Therapy in the Treatment of Fournier's Gangrene? A Retrospective Study. Front Surg 2022; 9:850378.
Rieger C, Huber M, Kastner L, et al. Center-based First-line Therapy Is a Significant Predictor for Mortality of Fournier Gangrene. JU Open Plus 2023; 1.
Bermani BF, Rizaliyana S, Handriani I. Predisposition Factors Analysis for Fournier’s Gangrene Defects Closure Complication. J Rekon Est 2021; 5:13
Radcliffe RS, Khan MA. Mortality associated with Fournier's gangrene remains unchanged over 25 years. BJU Int 2020; 125:610-616.
Laor E, Palmer LS, Tolia BM, et al. Outcome Prediction in Patients with Fournier's Gangrene. J Urol 1995; 154:89-92.
Noegroho BS, Siregar S, Mustafa A, Rivaldi MA. Validation of FGSI Scores in Predicting Fournier Gangrene in Tertiary Hospital. Res Rep Urol 2021; 13:341-346.
Yim SU, Kim SW, Ahn JH. et al. Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Are More Effective than the Fournier's Gangrene Severity Index for Predicting Poor Prognosis in Fournier's Gangrene. Surg Infect 2016; 17:217-223.
Kosidlo JW, Wolszczak-Biedrzycka B, Matowicka-Karna J, et al. Clinical Significance and Diagnostic Utility of NLR, LMR, PLR and SII in the Course of COVID-19: A Literature Review. J Inflamm Res 2023; 16:539-562.
Kose N, Yildirim T, Akin F, et al. Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? Author's reply on commentary. Bosn J Basic Med Sci 2021; 21:502.
Kincius M, Telksnys T, Trumbeckas D, et al. Evaluation of LRINEC Scale Feasibility for Predicting Outcomes of Fournier Gangrene. Surg Infect 2016; 17:448-453.

How to Cite

Wirjopranoto, S., Affandi, M. R., Ashari, F. Y., Azmi, Y. A., & Soetanto, K. M. (2024). Evaluating prognostic indicators for in-hospital mortality in Fournier’s gangrene: a 7-year study in a tertiary hospital. Archivio Italiano Di Urologia E Andrologia, 96(2). https://doi.org/10.4081/aiua.2024.12387